What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Park Medi World Limited IPO?

Park Medi World Limited IPO has received a total subscription of 8.52 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Park Medi World Limited

ListedMainboard

Healthcare · NSE / BSE

Park Medi World Limited, incorporated in 2011, is a leading private hospital chain in North India operating 13 NABH-accredited multi-super speciality hospitals with a total capacity of 3,000 beds across Haryana, Delhi, Punjab, and Rajasthan, of which seven are also NABL accredited. The network offers 30+ specialities including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology, supported by 805 ICU beds, 63 operating theatres, two dedicated cancer units, and oxygen generation plants at every hospital. As of September 30, 2024, the group handled 40,368 in-patient admissions in six months (73,284 in FY24) and employed 891 doctors, 1,912 nurses, 671 medical professionals, and 1,761 support staff.

Price Band

₹154 – ₹162

Issue Size

₹920 Cr

Lot Size

92 shares

GMP

₹5

+3.1%

Est. Listing

₹167

at current GMP

Subscribed

8.52x

overall

Open

10 Dec 2025

12 Dec 2025

Allotment

15 Dec 2025

Refund

16 Dec 2025

Demat Credit

17 Dec 2025

Listing

17 Dec 2025

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

8.52x

Total Demand

QIB Multiplier

12.07x

Institutions & Funds

NII / HNI

15.93x

High Net-Worth

Retail (RII)

3.32x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 8.52x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	11,358,026	137,109,808	12.07x
NIB	8,518,519	135,718,492	15.93x
HNIs(10L +)	5,679,012	104,155,592	18.34x
HNIs (2-10L)	2,839,506	31,562,900	11.12x
RETAIL	19,876,543	66,002,272	3.32x
Total	48,271,606	474,549,064	8.52x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 2.92x

Category	Applications Reserved	Applications Received	Times Subscribed
RETAIL	216,049	610,981	2.83x
HNIs(10L +)	4,409	15,638	3.55x
HNIs (2-10L)	2,205	23,611	10.71x
Total Applications	222,663	650,230	2.92x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Park Medi World Limited Public Issue & Market Profile

Park Medi World Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹920 Crores. The shares are offered at a price band of ₹154 to ₹162 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 92 shares (approx. ₹14,904 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-12-17, while un-allotted funds or UPI block mandates will be released on 2025-12-16.

Frequently Asked Questions

What is Park Medi World Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Park Medi World Limited IPO is ₹5 per equity share. Based on the upper price band of ₹154 to ₹162 per equity share, the estimated listing price is ₹167 (+3.1% expected listing gain).

What is the expected profit per lot for Park Medi World Limited IPO?

With a lot size of 92 shares and current GMP of ₹5, the expected profit per application lot is approx ₹460 (+3.1% gain). Minimum application cost is approx ₹14,904.

What is the issue size and price band for Park Medi World Limited IPO?

The Park Medi World Limited IPO aggregate issue size is ₹920 Crores with an equity price band set at ₹154 to ₹162 per equity share. The retail lot size is 92 shares requiring a minimum capital outlay of approx. ₹14,904.

How can I check Park Medi World Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 8.52x (Retail: 3.32x, QIB: 12.07x, NII: 15.93x). You can track live multiples directly on our dedicated subscription page.

Where and when will Park Medi World Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-12-15. Investors can verify status using PAN card or application number.

When is the listing date for Park Medi World Limited IPO?

Park Medi World Limited shares are scheduled to list on NSE and BSE on 2025-12-17.